Literature DB >> 12493779

Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection.

Christoph G Lange1, Michael M Lederman.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12493779     DOI： 10.1093/jac/dkg071

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Authors:  H Lim; L Kane; J B Schwartz; C S Hesdorffer; S G Deeks; N Greig; L Ferrucci; E J Goetzl
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 2.  Immune-based therapies: an adjunct to antiretroviral treatment.

Authors:  Jeffrey M Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

3.  In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.

Authors:  Benigno Rodriguez; Hernan Valdez; Christoph G Lange; Robert Asaad; Kathy Medvik; Scott F Sieg
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

4.  Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals.

Authors:  Lia Vassena; Michael Proschan; Anthony S Fauci; Paolo Lusso
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

Review 5.  Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection.

Authors:  Lori L Hudson; M Louise Markert; Blythe H Devlin; Barton F Haynes; Gregory D Sempowski
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

6.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

7.  Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection.

Authors:  M V Ragni; M A Nalesnik; R Schillo; Q Dang
Journal:  Haemophilia       Date:  2009-03       Impact factor: 4.287

8.  Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.

Authors:  Jerome Kerzerho; Elizabeth J McIlvaine; Patricia Anthony; Wendy J Mack; Chia-Hao Wang; Toni Frederick; Eva Operskalski; Zhi Chen; Lena Al-Harthi; Alan Landay; Mary A Young; Phyllis C Tien; Michael Augenbraun; Howard D Strickler; Omid Akbari; Elizabeth T Golub; Gerald B Sharp; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

9.  Immunity in HIV-1-infected adults with a previous state of moderate-severe immune-suppression and more than 500 CD4+ T cell after highly active antiretroviral therapy.

Authors:  Salvador Resino; Laura Rivero; Ezequiel Ruiz-Mateos; Isabel Galán; Jaime Munoz Franco; Maria Angeles Munoz-Fernández; Manuel Leal
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

10.  Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy.

Authors:  Natascha M Minidis; Octavio Mesner; Brian K Agan; Jason F Okulicz
Journal:  J Int AIDS Soc       Date:  2014-02-04       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.